Name change coincides with US parent company Columbia Laboratories becoming Juniper Pharmaceuticals Inc
Nikin Patel: The single Juniper brand formalises the experience and capabilities that have been built in Boston and Nottingham
Nottingham, UK-based contract development and manufacturing organisation (CDMO) Molecular Profiles has changed its name to Juniper Pharma Services.
The move coincides with its Boston, MA, US-based parent company Columbia Laboratories adopting a new brand identity as Juniper Pharmaceuticals Inc.
The company also has a new website at www.juniperpharma.com.
Nikin Patel, President of Juniper Pharma Services, said: 'The single Juniper brand formalises the experience and capabilities that have been built in Boston and Nottingham. The name change also coincides with the expansion of our service offering to the North American market.'
Juniper Pharma Services specialises in advanced characterisation, IP consulting, formulation development, analytical services and clinical manufacturing.
The CDMO has well established tableting and capsule filling capabilities focused on delivering product supply for small scale early trials up to Phase III and the rebranding coincides with increased demand for topical and oral dosage form products.